Bazelet Group

Company Overview

Snapshot

Founded in January 2012 by Meir Ariel and Aharon (Ari) Eyal, Bazelet Group operates with 11–50 employees. The company is a cannabis scientific incubator focused on developing innovative enriched-cannabis products. In January 2021, Bazelet launched proprietary terpene-enriched medical cannabis oils designed for specific medical needs.

Business overview

Bazelet Group is a cannabis scientific incubator that develops innovative enriched-cannabis products. The company processes cannabis from legal farms in Israel, serving a significant patient base. Its product portfolio includes cannabis buds, ground flowers, cannabis cigarettes, extracts, vaporizer tablets, sustained-release capsules, topicals, and suppositories. Bazelet also provides secure home delivery, patient education, strain-selection advice, and operates a call center, while developing new technologies for vaporizers, veterinary applications, and novel delivery methods. The company operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology, focusing on Medical Cannabis and Drug Delivery.

Strategic signal

In June 2021, Bazelet Group entered a joint venture with Ayurcann, signaling a strategic expansion and validation of its position as a significant player in the medical cannabis market. This partnership indicates Bazelet's potential for broader market reach and collaborative product development, reinforcing its growth trajectory within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Bazelet Group's primary focus?

Bazelet Group is a cannabis scientific incubator dedicated to developing innovative enriched-cannabis products, operating within the Health Tech & Life Sciences sector.

When was Bazelet Group founded and by whom?

Bazelet Group was founded in January 2012 by Meir Ariel and Aharon (Ari) Eyal.

What new product did Bazelet Group launch in January 2021?

In January 2021, Bazelet Group launched proprietary terpene-enriched medical cannabis oils, specifically designed for medical needs such as women's health, pain treatment, improved sleep, and the elderly population.

What strategic partnership did Bazelet Group announce in June 2021?

In June 2021, Bazelet Group announced a new joint venture with Ayurcann, aiming to expand its operations and market presence.

What types of products does Bazelet Group offer?

Bazelet Group offers a range of medical cannabis products, including cannabis buds, ground flowers, cannabis cigarettes, extracts, vaporizer tablets, sustained-release capsules, topicals, and suppositories.